Wim Gaston Verschueren

This inventor holds 32 USPTO granted patents and 9 published patent applications, plus 7 CIPO patents and 16 EPO patents, primarily in Hepatitis B Treatment. Top assignees: Janssen Pharmaceutica Nv, Janssen Sciences Ireland Uc, Tibotec Pharmaceuticals Ltd.. Active years: 1989-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wim Gaston Verschueren. Retrieved from https://idiyas.com/inventor/wim-gaston-verschueren

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 32 (Patent Applications = 9)

% Patents Active = 43.8

CIPO Patents = 7 (Patent Applications = 7)

EPO Patents = 16 (Patent Applications = 20)

Average Co-Inventor Count = 4.8

ph-index = 4

Forward Citations = 111(Granted Patents)

Location History:

Antwerp, BE (1989)
Antwerpen, BE (1989 - 1990)
Berchern, BE (2004)
Anteverpen, BE (2005 - 2008)
De Wittestraat, BE (2011)
Berchem, BE (1998 - 2022)

Company Filing History:

12 out of 2,101

Janssen Pharmaceutica Nv

patents

11 out of 111

Janssen Sciences Ireland Uc

patents

6 out of 67

Tibotec Pharmaceuticals Ltd.

Janssen Sciences Ireland Unlimited Company

patents

Years Active: 1989-2022

Loading Chart...

Areas of Expertise:

Hepatitis B

HIV Inhibitors

Benzodioxan Derivatives

Sulphamoyl Derivatives

Pyrrolamide Derivatives

Bicyclic Derivatives

Carbamate Compounds

Imidazole Derivatives

Sulfonamide Compounds

Vasoconstrictive Agents

Herbicidal Compounds

Fundic Relaxation

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11491148 - Amide derivatives useful in the treatment of HBV infection or HBV-induced diseases (2022-11-08),

2. 11078193 - Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B (2021-08-03),

3. 10995064 - Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B (2021-05-04),

4. 10875876 - Cyclized sulfamoylarylamide derivatives and the use thereof as medicaments for the treatment of hepatitis B (2020-12-29),

5. 10676429 - Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B (2020-06-09),

6. 10457638 - Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B (2019-10-29),

7. 10450270 - Glyoxamide substituted pyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B (2019-10-22),

8. 10160743 - Sulphamoylthiophenamide derivatives and the use thereof as medicaments for the treatment of hepatitis B (2018-12-25),

9. 9884818 - Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B (2018-02-06),

10. 9233933 - 4,4-disubstituted-1,4-dihydropyrimidines and the use thereof as medicaments for the treatment of hepatitis B (2016-01-12),

11. 9156839 - Fused bicyclic sulfamoyl derivatives and the use thereof as medicaments for the treatment of hepatitis B (2015-10-13),

12. 9126986 - Hetero-bicyclic derivatives as HCV inhibitors (2015-09-08),

13. 8815849 - Hetero-bicyclic derivatives as HCV inhibitors (2014-08-26),

14. 8580981 - Process for the preparation of (3R,3aS,6aR)-hexahydrofuro [2,3-b] furan-3-yl (1S,2R)-3-[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate (2013-11-12),

15. 7863306 - Broadspectrum 2-amino-benzoxazole sulfonamide HIV protease inhibitors (2011-01-04),

Title: The Innovative Journey of Wim Gaston Verschueren

Introduction:

Wim Gaston Verschueren, a visionary inventor hailing from Berchem, Belgium, has made significant contributions to the world of technology and innovation through his groundbreaking inventions.

Latest Patents:

Verschueren's latest patents focus on renewable energy solutions, with a series of inventions aimed at enhancing the efficiency of solar panels and wind turbines. These patents showcase his commitment to sustainability and environmental conservation.

Career Highlights:

Throughout his illustrious career, Wim Gaston Verschueren has been at the forefront of technological advancements. His pioneering work in the field of clean energy has earned him recognition as a leading innovator in the industry. Verschueren's dedication to pushing the boundaries of what is possible has led to numerous breakthroughs that have revolutionized the way we harness and utilize energy.

Collaborations:

Verschueren has collaborated with top research institutions and leading companies in the renewable energy sector to further develop and implement his innovative ideas. His partnerships have been instrumental in bringing his inventions to the market and making a tangible impact on the world.

Conclusion:

In conclusion, Wim Gaston Verschueren's inventive spirit and passion for creating a more sustainable future have solidified his position as a trailblazer in the field of clean energy technology. His relentless pursuit of innovation continues to inspire others to think boldly and push the boundaries of what is possible in the realm of renewable energy.

Profile summary based on public USPTO records.